Skip to main content
. 2011 Jun 15;286(33):29127–29138. doi: 10.1074/jbc.M110.169771

FIGURE 5.

FIGURE 5.

Tunicamycin inhibits the growth of a triple negative breast tumor. The xenografts were developed in athymic nude mice after injecting MDA-MB-231 (ER/PR/EGFR) human breast cancer cells and treated with tunicamycin (0.25 mg/kg) orally twice a week. A, tumor size in a control xenograft (untreated) and after tunicamycin treatment (TM-treated); B, tumor volume (mm3) as a function of time. ◆---◆, control; ■---■, tunicamycin.